共 379 条
[1]
Jemal A(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
[2]
Siegel R(1997)Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers Int J Pancreatol 21 43-52
[3]
Xu J(1991)Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience J Immunother (1991) 10 426-431
[4]
Ward E(2002)Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer Int J Cancer 98 45-50
[5]
Friess H(1994)Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumors J Immunother Emphasis Tumor Immunol 16 216-223
[6]
Gassmann M(2010)Tumor antigen presentation by dendritic cells Crit Rev Immunol 30 345-386
[7]
Buchler MW(2004)Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates Cancer Immunol Immunother 53 715-722
[8]
Hersh EM(2001)Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer Hepatogastroenterology 48 347-351
[9]
Metch BS(2008)A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors Cancer Ther 6 955-964
[10]
Muggia FM(1990)Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin J Biol Chem 265 15286-15293